- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Omnicare (NYSE: OCR) hit a new 52-week high Thursday as it is currently trading at $36.51, above its previous 52-week high of $36.48 with 972,984 shares traded as of 11:25 a.m. ET. Average volume has been one million shares over the past 30 days. Omnicare has a market cap of $3.76 billion and is part of the services sector and wholesale industry. Shares are up 0.3% year to date as of the close of trading on Wednesday. Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. The company has a P/E ratio of 25.5, below the average wholesale industry P/E ratio of 28.8 and above the S&P 500 P/E ratio of 17.7.